Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ingrid Philippens"'
Autor:
Ferdinando Nicoletti, Ingrid Philippens, Paolo Fagone, Clarence N. Ahlem, Christopher L. Reading, James M. Frincke, Dominick L. Auci
Publikováno v:
Parkinson's Disease, Vol 2012 (2012)
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) is a synthetic androstenetriol in Phase II clinical development for the treatment of inflammatory diseases. HE3286 was evaluated for blood-brain barrier (BBB) permeability in mice, and efficacy i
Externí odkaz:
https://doaj.org/article/87c6993dba6844f7a3e9081dda6e9584
Publikováno v:
Current topics in behavioral neurosciences. 38
Despite efforts to develop more effective therapies, PTSD remains a difficult disorder to treat. Insight into the dynamic nature of memory formation and its required molecular machinery can provide an opportunity to target pathological memories for e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d8ed065cdc4cf421b5fdbdb89f058bc
https://pubmed.ncbi.nlm.nih.gov/29637527
https://pubmed.ncbi.nlm.nih.gov/29637527
Autor:
Christopher L. Reading, Clarence N. Ahlem, Ingrid Philippens, Ferdinando Nicoletti, James M. Frincke, Paolo Fagone, Dominick L. Auci
Publikováno v:
Parkinson's Disease. 2012:1-8
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) is a synthetic androstenetriol in Phase II clinical development for the treatment of inflammatory diseases. HE3286 was evaluated for blood-brain barrier (BBB) permeability in mice, and efficacy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b2a8970de874148c3c01c8898464108
https://doi.org/10.1155/2012/969418
https://doi.org/10.1155/2012/969418